Over 2 Years Ago
1 Min Read

BHC is making big moves today. Find out why the stock is trading -50% lower:



Shares of Bausch Health Companies Inc (BHC) are trading -50% lower at a price of $4.317 at the time of this writing.

  • Delaware federal judge ruled on a patent-related issue related to the company's Xifaxan drug

Bausch Health Companies Inc has been trading between a 52-week high of $30.01 and a 52-week low of $4. The stock has a market cap of $1.56 Billion.

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.

Headlines


Toronto stocks slip as mixed earnings, Bausch Health weigh
Financial Post 07-28-22

Toronto stocks slip as mixed earnings, Bausch Health weigh
Reuters 07-28-22

Bausch Health plummets 50% following judge''s Xifaxan patent order (NYSE:BHC)
Seeking Alpha 07-28-22

Better Therapeutics, GeoVax top healthcare gainers; Community Health, Bausch lead losers'' pack
Seeking Alpha 07-28-22

Bausch Health Companies Inc. Will Release Second-Quarter 2022 Financial Results on Aug. 9
PR Newswire 07-27-22


As you can imagine, the internet had a few things to say about the price move. Here's a few choice comments from the Reddit Traderverse™:

Tbones014 - 4 upvotes - source
Cramer claims more victims after recommending BHC

Sure-Ad7730 - 2 upvotes - source
Halt on BHC I was just about to jump in.

nationalizm - 1 upvotes - source
Imagine buying BHC puts yesterday lmao do they actually pay those options out for 15k gains if there’s no volume on them?

le_pedal - 1 upvotes - source
BHC